Jun Ji
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
Papers in
-
- Signaling Pathways in Disease 2
-
- Cancer Genomics and Diagnostics 2
- MicroRNA in disease regulation 2
- Co-authors
- Qu Cai (4 shared papers)Yingyan Yu (5 shared papers)Bingya Liu (5 shared papers)Zhenggang Zhu (4 shared papers)Jinling Jiang (3 shared papers)Min Shi (3 shared papers)Qianfu Zhao (2 shared papers)Jianfang Li (3 shared papers)
- Journals
- Anti-Cancer Agents in Medicinal Chemistry (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Molecular Biology Reports (1 paper)Oncogene (1 paper)Cell Research (1 paper)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Jun Ji
18 papers receiving 632 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 229
- Biological Psychiatry 22
- Oncology 132
- Immunology 101
- Molecular Biology 319
Countries citing papers authored by Jun Ji
This map shows the geographic impact of Jun Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ji more than expected).
Fields of papers citing papers by Jun Ji
This network shows the impact of papers produced by Jun Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ji. The network helps show where Jun Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 148 | |
| 2 | 2020 | 112 | |
| 3 | 2019 | 102 | |
| 4 | 2012 | 84 | |
| 5 | 2008 | 36 | |
| 6 | 2013 | 30 | |
| 7 | 2023 | 20 | |
| 8 | 2018 | 19 | |
| 9 | Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil. | 2011 | 18 |
| 10 | 2014 | 17 | |
| 11 | 2014 | 16 | |
| 12 | 2021 | 14 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 4 | |
| 17 | [Perforin and granzyme B expression in liver allograft rejection]. | 2004 | 2 |
| 18 | 2010 | 2 | |
| 19 | 2023 | 0 | |
| 20 | [Bone density changes in the apical area after rapid orthodontic extrusion of subgingivally fractured tooth]. | 2007 | 0 |
About Jun Ji
Jun Ji is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Periodontics, having authored 20 papers that have together received 637 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Oral microbiology and periodontitis research (2 papers), Peptidase Inhibition and Analysis (2 papers), Signaling Pathways in Disease (2 papers), MicroRNA in disease regulation (2 papers), Ferroptosis and cancer prognosis (1 paper), Galectins and Cancer Biology (1 paper) and Orthodontics and Dentofacial Orthopedics (1 paper). The work is most often cited by research in Cancer Research (229 citations), Biological Psychiatry (22 citations), Oncology (132 citations), Immunology (101 citations) and Molecular Biology (319 citations). Jun Ji has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Qu Cai, Yingyan Yu, Bingya Liu, Zhenggang Zhu, Jinling Jiang, Min Shi, Qianfu Zhao, Jianfang Li, Zhenggang Zhu and Chao Wang. Their work appears in journals such as Anti-Cancer Agents in Medicinal Chemistry, Therapeutic Advances in Medical Oncology, Molecular Biology Reports, Oncogene and Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.